10.3760/cma.j.issn.2096-5540.2018.03.005
Updated review of IL-17 inhibitors for psoriasis treatment
Introduction Psoriasis is a chronic,immune-mediated inflammatory skin disease.The pathogenic characters of psoriasis are remarkable proliferation,unusual differentiation and immune activation of keratinocytes,accompanied with disorderly immune system”1”.Psoriasis patients suffered from tremendous psychosocial burden,and remarkable reduction of physical activity and quality of life”2”.
1
The work was supported by CAMS Innovation Fund for Medical SciencesCIFMS-2017-I2M-1-017;the Natural Science Foundation of Jiangsu ProvinceBK20161123
2018-10-29(万方平台首次上网日期,不代表论文的发表时间)
共7页
157-163